UROGENITAL DISORDERS IN WOMEN OF REPRODUCTIVE AGE WITH ANDROGEN DEFICIENCY
According to the consensus of An Endocrine Society Clinical Practice in Princeton, USA, worsening well-being and dystrophic mood, permanent weakness and altered sexual function, including libido decline and lack of orgasm, were considered as typical signs of androgen deficiency syndrome. Particular attention is required to study the state of the genitourinary system, which is hormone dependent, so it is obvious that age-associated symptoms of pathological processes of the lower urinary tract are likely to be considered as a "urological mask" of the deficiency of sex hormones.
Aim of the work. Identify and describe the most common urogenital disorders in women of reproductive age with androgen deficiency.
Materials and methods. The study was conducted at the Ukrainian Scientific and Practical Center of Endocrine Surgery, Endocrine organs and tissues transplantation of the Ministry of Health of Ukraine during 2017–2018 years. A survey was conducted on 80 women of reproductive age who had major complaints of sexual disturbances (decreased libido and lack of orgasm, as well as dyspareunia as the main manifestations of androgen deficiency in women) and 30 healthy reproductive women without complaints of sexual dysfunction. General clinical methods were used (questionnaire of patients with a detailed study of socio-economic status, somatic, gynecological, obstetric and sexual history). The condition of external and internal genital organs was evaluated in the study of cervix and vagina in mirrors and gynecological bimanual study. At the same time, batches of analyzes for bacteriological research and colpocytology studies were conducted. The “HAWK 2102 EXL” (Germany) apparatus was used for ultrasound examination of pelvic organs using transabdominal and transvaginal convection sensors with frequencies of 3.5 and 5 MHz, respectively. Consultation of the urologist in order to exclude organic urological pathology and, if necessary, cystoscopy was also done.
In the plasma of venous blood, the following hormonal indices were also determined by solid phase IFA, namely, content: free testosterone, DHEA, androstenedione, prolactin, ACTH, cortisol, FSH, LH, estradiol, progesterone.
Results. It was revealed after exclusion of the urologist of the organic pathology of the urinary tract, in 49 % (39) of the main group, there were disturbances of urination associated with atrophic changes in the distal sections of the urinary tract. The revealed signs of vulvovaginal atrophy: pH 6.1±0.7 in women of the main group and pH 4.3±0.5 in women of the control group, in addition reduction of the karyopyknotic index and increase of the ripening index as signs of atrophic changes in the vaginal mucosa and cervical canal, was detected in 70 % (56) women in the main group and not found in the control group. At the same time, the prolapse of the genitalia of mild degree in women of the main group was detected in 32 % (27), and in the control group, this pathology was not found.
Conclusions. Detection of these changes, which was considered characteristic of women in perimenopause and postmenopausal, makes it important and valid for the continuation of the study of patients with androgen deficiency, the discovery of clinical and laboratory criteria for diagnosis and the development of methods for correcting androgen deficiency in women of all ages.
Bosdou, J. K., Venetis, C. A., Kolibianakis, E. M., Toulis, K. A., Goulis, D. G., Zepiridis, L., Tarlatzis, B. C. (2012). The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update, 18 (2), 127–145. doi: https://doi.org/10.1093/humupd/dmr051
Davey, D. A. (2012). Androgens in Women before and after the Menopause and Post Bilateral Oophorectomy: Clinical Effects and Indications for Testosterone Therapy. Women’s Health, 8 (4), 437–446. doi: https://doi.org/10.2217/whe.12.27
Berman, J. R., Almeida, F. G., Jolin, J., Raz, S., Chaudhuri, G., Gonzalez-Cadavid, N. F. (2003). Correlation of androgen receptors, aromatase, and 5-α reductase in the human vagina with menopausal status. Fertility and Sterility, 79 (4), 925–931. doi: https://doi.org/10.1016/s0015-0282(02)04923-3
Buster, J. E., Kingsberg, S. A., Aguirre, O., Brown, C., Breaux, J. G., Buch, A. et. al. (2005). Testosterone Patch for Low Sexual Desire in Surgically Menopausal Women: A Randomized Trial. Obstetrics & Gynecology, 105 (5), 944–952. doi: https://doi.org/10.1097/01.aog.0000158103.27672.0d
Hano, M., Malkovich, S., Veyn, A. Dzh. (2006). Rukovodstvo po klinicheskoy urologii. Moscow: GEOTAR-Media, 543.
Ho, M. H., Bhatia, N. N., Bhasin, S. (2004). Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract. Current Opinion in Obstetrics and Gynecology, 16 (5), 405–409. doi: https://doi.org/10.1097/00001703-200410000-00009
Davison, S. L., Bell, R., Donath, S., Montalto, J. G., Davis, S. R. (2005). Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy. The Journal of Clinical Endocrinology & Metabolism, 90 (7), 3847–3853. doi: https://doi.org/10.1210/jc.2005-0212
Maia, H., Casoy, J., Valente, J. (2009). Testosterone replacement therapy in the climacteric: Benefits beyond sexuality. Gynecological Endocrinology, 25 (1), 12–20. doi: https://doi.org/10.1080/09513590802360744
Edwall, L., Carlström, K., Jonasson, A. F. (2005). Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence. Neurourology and Urodynamics, 24 (4), 319–324. doi: https://doi.org/10.1002/nau.20142
Edwall, L., Carlström, K., Jonasson, A. F. (2007). Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourology and Urodynamics, 26 (3), 410–415. doi: https://doi.org/10.1002/nau.20335
Pessina, M. A., Hoyt, R. F., Goldstein, I., Traish, A. M. (2006). Differential Effects of Estradiol, Progesterone, and Testosterone on Vaginal Structural Integrity. Endocrinology, 147 (1), 61–69. doi: https://doi.org/10.1210/en.2005-0870
Panjari, M., Davis, S. R. (2011). Vaginal DHEA to treat menopause related atrophy: A review of the evidence. Maturitas, 70 (1), 22–25. doi: https://doi.org/10.1016/j.maturitas.2011.06.005
Kokot-Kierepa, M., Bartuzi, A., Kulik-Rechberger, B., Rechberger, T. (2012). Local estrogen therapyclinical implications-2012 update. Ginekol Pol., 83 (10), 772–777.
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., Santoro, N. (2006). Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 91 (10), 3697–3710. doi: https://doi.org/10.1210/jc.2006-1121
Khaidarova, F. A., Nigmatova, S. S. (2012). Testosterone and quality of women’s life (literature review). Mezhdunarodniy endokrinologicheskiy zhurnal, 2 (42), 137–142.
Copyright (c) 2018 Lesia Demianenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.